Pediatrics Study in Mucopolysaccharidosis type III (MPSIIIA)
Discover how our scientists performed an open, non-controlled, parallel, ascending multiple-dose, multicentre…
Read more
SARS-Cov-2 ELISpot: a new test in the Covid-19 diagnostic and vaccine arsenal
Following SARS-CoV-2 infection, an innate immune response occurs rapidly at the infection…
Read more
Tech Transfer China for IFE Reflex Assay
Biotech Company in China required our scientific expertise for the Tech Transfer…
Read more
Turning Precision Medicine into Action
CerbACT Asia empowers precision medicine development and drives better patient outcomes by…
Read more
Measurable success: The value of Biomarkers From Discovery Through Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Solid tumor analytical validation of a T-regulatory immunohistochemistry multiplex for clinical studies
Accurate characterization of the tumor micro-environment when tissue sample access is limited…
Read more
Change the shape of your clinical development
At Cerba Research we are built on more than 50 years of…
Read more
How Saint-Antoine Hospital is boosting patient recruitment with medical laboratory data
A staggering number of clinical trials fail to enroll enough patients. Most…
Read more
The new big data application that is reshaping clinical trials
The new big data application is reshaping clinical trials. Someone on the…
Read more
Matching patients to trials: Cerba Research’s digital tool for improved patient recruitment
Patient recruitment has always been a challenge for clinical research, with most…
Read more
Phase 3 CAR-T vs SOC in Relapse Refractory Multiple Myeloma (RRMM)
Discover how effective we are in immunophenotyping for a Car-T therapy take…
Read more
Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we manage routine and specialty test for a Phase 1…
Read more
Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we managed cell isolation and counts among other routine and…
Read more
The Value of Biomarkers from Discovery to Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings
Cerba Research established its United States presence as a leading clinical diagnostics…
Read more
How Cerba Research helped advance a Phase 1B study in the middle of a pandemic and Brexit
A two-country clinical trial that involves a nasopharyngeal swab and two assays…
Read more
Tech Transfer IFE Reflex Assay China
A Biotech Company in China required our scientific expertise for the Tech…
Read more
Pediatric Phase I/II/III Study in X-Linked Myotubular Myopathy (XLMTM)
Lab support for a global pediatric trial for the rare neuromuscular disease,…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.
Contact Us